Waters Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Waters ha aumentado sus beneficios a una tasa media anual de 4.9%, mientras que los beneficios de la industria de Life Sciences han experimentado un crecimiento de 16.4% anual. Los ingresos han ido creciendo a una tasa media de 6.1% al año. La rentabilidad financiera de Waters es de 55.8%, y sus márgenes netos son de 21.7%.
Información clave
4.9%
Tasa de crecimiento de los beneficios
9.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Life Sciences | 21.5% |
| Tasa de crecimiento de los ingresos | 6.1% |
| Rentabilidad financiera | 55.8% |
| Margen neto | 21.7% |
| Próxima actualización de resultados | 07 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 25
Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?
Apr 07We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt
Mar 19Waters Corporation: A Great (Share Price) Run
Mar 11Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323
Feb 09Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings
Jan 09Waters Corporation: High Quality Niche Company In Mass Spectrometry
Dec 28A Look At The Fair Value Of Waters Corporation (NYSE:WAT)
Dec 10Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Nov 25Waters Corporation: Appealing Levels Are Offset By Weaker Performance
Nov 13Waters (NYSE:WAT) Seems To Use Debt Quite Sensibly
Oct 26Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)
Sep 27What Does Waters Corporation's (NYSE:WAT) Share Price Indicate?
Aug 21Calculating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Aug 03Waters Corporation: Temporary Headwinds Present A Buying Opportunity
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jul 16Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
May 23A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 29Here's Why Waters (NYSE:WAT) Can Manage Its Debt Responsibly
Apr 08What Is Waters Corporation's (NYSE:WAT) Share Price Doing?
Feb 22Waters Q4 2022 Earnings Preview
Feb 14Waters Corp.: Now Best Price-Positioned Medical Services Stock
Feb 02Waters Corporation (NYSE:WAT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 26Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?
Jan 05Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Nov 24Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363
Nov 16Waters Q3 2022 Earnings Preview
Oct 31Estimating The Fair Value Of Waters Corporation (NYSE:WAT)
Oct 19Waters announces €6M R&D investment at Wexford facility
Oct 07Is Waters (NYSE:WAT) Using Too Much Debt?
Oct 01Do Waters' (NYSE:WAT) Earnings Warrant Your Attention?
Aug 23Waters Corporation: Thesis Unchanged
Aug 18Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Aug 05Waters Non-GAAP EPS of $2.75 beats by $0.08, revenue of $714M beats by $7.23M
Aug 02Calculating The Fair Value Of Waters Corporation (NYSE:WAT)
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jun 30Waters Corporation: Shares Are Getting Cheaper, But They Aren't Cheap Enough
Jun 01Here's Why We Think Waters (NYSE:WAT) Is Well Worth Watching
May 15Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
Apr 29Waters Corporation (NYSE:WAT) Shares Could Be 22% Below Their Intrinsic Value Estimate
Apr 11Is Waters (NYSE:WAT) A Risky Investment?
Mar 25Waters Corporation: We Can Find Better Investments Out There
Mar 21If You Like EPS Growth Then Check Out Waters (NYSE:WAT) Before It's Too Late
Feb 03Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Jan 19A Look At The Fair Value Of Waters Corporation (NYSE:WAT)
Jan 04Waters Corporation: A Good Company At A Hefty Price
Jan 02Is Waters (NYSE:WAT) Using Too Much Debt?
Dec 20Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Waters. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 2,956 | 642 | 697 | 175 |
| 30 Sep 23 | 2,995 | 653 | 729 | 179 |
| 01 Jul 23 | 2,992 | 675 | 696 | 180 |
| 01 Apr 23 | 2,966 | 689 | 682 | 178 |
| 31 Dec 22 | 2,972 | 708 | 658 | 176 |
| 01 Oct 22 | 2,950 | 697 | 658 | 171 |
| 02 Jul 22 | 2,901 | 702 | 645 | 170 |
| 02 Apr 22 | 2,868 | 705 | 641 | 171 |
| 31 Dec 21 | 2,786 | 693 | 627 | 168 |
| 02 Oct 21 | 2,736 | 695 | 606 | 165 |
| 03 Jul 21 | 2,671 | 660 | 563 | 158 |
| 03 Apr 21 | 2,509 | 616 | 541 | 144 |
| 31 Dec 20 | 2,365 | 522 | 555 | 141 |
| 26 Sep 20 | 2,295 | 504 | 507 | 138 |
| 27 Jun 20 | 2,278 | 515 | 524 | 138 |
| 28 Mar 20 | 2,358 | 537 | 522 | 143 |
| 31 Dec 19 | 2,407 | 592 | 526 | 143 |
| 28 Sep 19 | 2,405 | 577 | 582 | 144 |
| 29 Jun 19 | 2,406 | 580 | 584 | 145 |
| 30 Mar 19 | 2,403 | 591 | 589 | 144 |
| 31 Dec 18 | 2,420 | 594 | 585 | 143 |
| 29 Sep 18 | 2,392 | 55 | 543 | 140 |
| 30 Jun 18 | 2,380 | 51 | 550 | 139 |
| 31 Mar 18 | 2,342 | 27 | 540 | 136 |
| 31 Dec 17 | 2,309 | 20 | 545 | 133 |
| 30 Sep 17 | 2,251 | 548 | 512 | 130 |
| 01 Jul 17 | 2,212 | 537 | 501 | 127 |
| 01 Apr 17 | 2,190 | 533 | 502 | 127 |
| 31 Dec 16 | 2,167 | 522 | 512 | 125 |
| 01 Oct 16 | 2,125 | 498 | 508 | 121 |
| 02 Jul 16 | 2,099 | 490 | 509 | 121 |
| 02 Apr 16 | 2,057 | 467 | 502 | 119 |
| 31 Dec 15 | 2,042 | 469 | 493 | 119 |
| 03 Oct 15 | 2,040 | 469 | 498 | 119 |
| 04 Jul 15 | 2,032 | 467 | 496 | 116 |
| 04 Apr 15 | 2,019 | 457 | 501 | 112 |
| 31 Dec 14 | 1,989 | 432 | 502 | 108 |
| 27 Sep 14 | 1,971 | 422 | 501 | 106 |
| 28 Jun 14 | 1,935 | 406 | 500 | 102 |
| 29 Mar 14 | 1,904 | 399 | 495 | 100 |
| 31 Dec 13 | 1,904 | 450 | 493 | 101 |
| 28 Sep 13 | 1,861 | 484 | 484 | 99 |
| 29 Jun 13 | 1,853 | 485 | 479 | 99 |
Ingresos de calidad: WAT tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(21.7%) de WAT son inferiores a los del año pasado (23.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de WAT han crecido un 4.9% al año en los últimos 5 años.
Acelerando crecimiento: WAT ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: WAT tuvo un crecimiento negativo de los beneficios (-9.3%) durante el año pasado, lo que dificulta la comparación con la media de la industria Life Sciences (-6.6%).
Rentabilidad financiera
Alta ROE: Aunque la rentabilidad financiera (55.83%) de WAT es excepcional, esta métrica está sesgada debido a su alto nivel de deuda.